Literature DB >> 19119061

DNA interaction studies of a platinum(II) complex, PtCl(2)(NN) (NN=4,7-dimethyl-1,10-phenanthroline), using different instrumental methods.

Nahid Shahabadi1, Soheila Kashanian, Mehdi Purfoulad.   

Abstract

The Pt(II) complex, PtCl(2)(4,7-Me(2)phen) (4,7-Me(2)phen=chelating dinitrogen ligand: 4,7-dimethyl-1,10-phenanthroline) was synthesized and characterized by spectroscopic ((1)H, (13)C NMR) and elemental analysis techniques. Binding interaction of this complex with calf thymus (CT) DNA has been investigated by emission, absorption, circular dichroism, viscosity and DNA thermal denaturation studies. The complex displays significant binding properties to the CT DNA. In fluorimeteric studies, the binding mode of complex with CT DNA was studied by using methylene blue as a fluoresce probe. As evidenced by the increasing fluorescence of methylene blue-DNA solutions in presence of increasing amount of complex, PtCl(2)(NN) complex is able to displace the methylene blue intercalated into DNA completely as to indicate intercalation. Furthermore, mentioned complex induces detectable changes in the CD spectrum of CT-DNA, an increase in T(m) value, and an increase in its viscosity. The experimental results showed that Pt(II) complex bound to DNA by an intercalative mode of binding.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19119061     DOI: 10.1016/j.saa.2008.11.022

Source DB:  PubMed          Journal:  Spectrochim Acta A Mol Biomol Spectrosc        ISSN: 1386-1425            Impact factor:   4.098


  9 in total

1.  Discrepancy between in vitro and in vivo antitumor effect of a new platinum(II) metallointercalator.

Authors:  Johnny Moretto; Bruno Chauffert; François Ghiringhelli; Janice R Aldrich-Wright; Florence Bouyer
Journal:  Invest New Drugs       Date:  2010-06-10       Impact factor: 3.850

2.  The mechanism of antimalarial action of [Au(CQ)(PPh(3))]PF(6): structural effects and increased drug lipophilicity enhance heme aggregation inhibition at lipid/water interfaces.

Authors:  Maribel Navarro; William Castro; Alberto Martínez; Roberto A Sánchez Delgado
Journal:  J Inorg Biochem       Date:  2010-11-13       Impact factor: 4.155

3.  Molecular aspects on the interaction of isatin-3-isonicotinylhydrazone to deoxyribonucleic acid: model for intercalative drug-DNA binding.

Authors:  Soheila Kashanian; Mohammad Mehdi Khodaei; Parvaneh Pakravan; Hadi Adibi
Journal:  Mol Biol Rep       Date:  2011-07-21       Impact factor: 2.742

4.  Identification of Binding Mode of a Platinum (II) Complex, PtCl(2)(DIP), and Calf Thymus DNA.

Authors:  Nahid Shahabadi; Soheila Kashanian; Azadeh Fatahi
Journal:  Bioinorg Chem Appl       Date:  2011-10-24       Impact factor: 7.778

5.  (2,9-Dimethyl-1,10-phenanthroline-κN,N')diiodidocadmium.

Authors:  Ismail Warad; Ahmed Boshaala; Saud I Al-Resayes; Salem S Al-Deyab; Mohamed Rzaigui
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2011-11-02

6.  DNA Interaction and DNA Cleavage Studies of a New Platinum(II) Complex Containing Aliphatic and Aromatic Dinitrogen Ligands.

Authors:  Nahid Shahabadi; Soheila Kashanian; Maryam Mahdavi; Noorkaram Sourinejad
Journal:  Bioinorg Chem Appl       Date:  2011-12-22       Impact factor: 7.778

7.  Biological Impact of Pd (II) Complexes: Synthesis, Spectral Characterization, In Vitro Anticancer, CT-DNA Binding, and Antioxidant Activities.

Authors:  Nitin Kumar Sharma; Rakesh Kumar Ameta; Man Singh
Journal:  Int J Med Chem       Date:  2016-02-16

8.  Benzimidazole-1,2,3-triazole hybrid molecules: synthesis and study of their interaction with G-quadruplex DNA.

Authors:  Padma S Singu; Ushasri Chilakamarthi; Namita S Mahadik; Bhamidipati Keerti; Narasimhulu Valipenta; Santosh N Mokale; Narayana Nagesh; Ravindra M Kumbhare
Journal:  RSC Med Chem       Date:  2021-02-22

9.  Antibacterial Activity of Co(III) Complexes with Diamine Chelate Ligands against a Broad Spectrum of Bacteria with a DNA Interaction Mechanism.

Authors:  Katarzyna Turecka; Agnieszka Chylewska; Michał Rychłowski; Joanna Zakrzewska; Krzysztof Waleron
Journal:  Pharmaceutics       Date:  2021-06-24       Impact factor: 6.321

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.